Circulating cytokines and nitric oxide are involved in the inhibition of neutrophil migration in patients with uterine cervical neoplasia

Clinical Medicine Insights: Oncology

Volumn 6, Issue , 2012, Pages 233-242

  Micheli, Douglas Côbo ^a   Fernandes, Paulo Cesar ^a   Cruvinel, João Celso Garcia ^a   Nomelini, Isabela Destro ^a   Murta, Eddie Fernando Candido ^a   Tavares Murta, Beatriz Martins ^a  

^a FEDERAL UNIVERSITY OF TRIÂNGULO MINEIRO   (Brazil)

Author keywords

Cervical cancer; Cytokine; Neutrophil function; Nitric oxide; Tumor stage

Indexed keywords

CHEMOATTRACTANT; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; NITRIC OXIDE; NITRITE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CANCER PATIENT; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN CELL; LEUKOCYTE CULTURE; LEUKOCYTE MIGRATION INHIBITION; MONONUCLEAR CELL; NEUTROPHIL CHEMOTAXIS; PROTEIN BLOOD LEVEL; SUPERNATANT; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX TUMOR;

EID: 84863884882     PISSN: None     EISSN: 11795549     Source Type: Journal    
DOI: 10.4137/CMO.S9518     Document Type: Article

References (33)

1. Koga Y, Matsuzaki A, Suminoe A, Hattori H, Hara T. Neutrophil-derived TNF related Apoptosis-Inducing Ligand (TRAIL): A novel mechanism of antitumor effect by neutrophils. Cancer Res. 2004;64:1037-43.
2. Houghton AM. The paradox of tumor-associated neutrophils: Fueling tumor growth with cytotoxic substances. Cell Cycle. 2010;9:1732-7.
3. Elsasser D, Valerius T, Repp R, Weiner GJ, Deo Y, Kalden JR, et al. HLA class II as potential target antigen on malignant B cells for therapy with bispecific antibodies in combination with granulocyte colony-stimulating factor. Blood. 1996;87:3803-12.
4. Siders WM, Shields J, Garron C, Hu Y, Boutin P, Shankara S, et al. Involvement of neutrophils and natural killer cells in the anti-tumor activity of alemtuzumab in xenograft tumor models. Leuk Lymphoma. 2010;51:1293-304.
5. Lukac J, Kusic Z, Kovacevic D, Soldic Z, Troskot B. Neutrophil and monocyte phagocytic functions in patients with colorectal adenocarcinoma during fluoruracil therapy. Anticancer Res. 1995;15:2805-10.
6. Póka R, Szûcs S, Ádány R, Szikszay E. Stage-related superoxide anion production of granulocytes of gynecologic cancer patients. Eur J Obstet and Gynecol and Reprod Biol. 2000;89:55-7.
7. Gordon IO, Freedman RS. Defective antitumor function of monocytederived macrophages from epithelial ovarian cancer patients. Clin Cancer Res. 2006;12:1515-24.
8. Richards JO, Chang X, Blaser BW, Caligiuri MA, Zheng P, Liu Y. Tumor growth impedes natural-killer-cell maturation in the bone marrow. Blood. 2006;108:246-52.
9. Demirkazik A, Kessinger A, Lynch J, Reed E, Terantolo S, Sharp JG. Effect of prior therapy and bone marrow metastases on progenitor cell content of blood stem cell harvests in breast cancer patients. Biol Blood Marrow Transplant. 2002;8:268-72.
10. Lang S, Lauffer L, Clausen C, Lohr I, Schmitt B, Hotzel D, et al. Impaired monocyte function in cancer patients: restoration with a ciclooxigenase-2 inhibitor. FASEB J. 2003;17:286-8.
11. Mendonça MAO, Cunha FQ, Murta EFC, Tavares-Murta BM. Failure of neutrophil chemotactic function in breast cancer patients treated with chemotherapy. Cancer Chemother Pharmacol. 2006;57:663-70.
12. Benjamim CF, Ferreira SH, Cunha FQ. Role of nitric oxide in the failure of neutrophil migration in sepsis. J Infect Dis. 2000;182:214-23.
13. Gogos CA, Drosou E, Bassaris HP, Skoutelis A. Pro-versus anti-inflammatory cytokine profile in patients with severe sepsis: A marker for prognosis and future therapeutic options. J Infect Dis. 2000;181: 176-80.
14. Fernandes PC Jr, Garcia CB, Micheli DC, Cunha FQ, Murta EFC, Tavares-Murta BM. Circulating neutrophils may play a role in the host response in cervical cancer. Int J Gynecol Cancer. 2007;17: 1068-74.
15. Garcia CB, Fernandes PC Jr, Micheli DC, Pereira AHM, Murta EFC, Tavares-Murta BM. Effect of treatment on mononuclear cell migration in cervical cancer patients. Tumori. 2008;94:712-7.
16. Green LC, Ruiz de Luzuriaga K, Wagner DA, Rand W, Istfan N, Young VR, et al. Nitrate biosynthesis in man. Proc Natl Acad Sci U S A. 1981;78: 7764-8.
17. Kousis PC, Henderson BW, Maier PG, Gollnick SO. Photodynamic therapy enhancement of antitumor immunity is regulated by neutrophils. Cancer Res. 2007;67:10501-10.
18. Challacombe JM, Suhrbier A, Parsons PG, Jones B, Hampson P, Kavanagh D, et al. Neutrophils are a key component of the antitumor efficacy of topical chemotherapy with ingenol-3-angelate. J Immunol. 2006; 177:8123-32.
19. Dissemond J, Weimann TK, Schneider LA, Schneeberger A, Scharffetter-Kochanek K, Goos M, et al. Activated neutrophils exert antitumor activity against human melanoma cells: reactive oxygen species-induced mechanisms and their modulation by granulocyte-macrophage-colony-stimulating factor. J Invest Dermatol. 2003;121:936-8.
20. Dumitru CA, Gholaman H, Trellakis S, Bruderek K, Dominas N, Gu X, et al. Tumor-derived macrophage migration inhibitory factor modulates the biology of head and neck cancer cells via neutrophil activation. Int J Cancer. 2011;129:859-69.
21. Tavares-Murta BM, Cunha FQ, Ferreira SH. The intravenous administration of tumor necrosis factor alpha, interleukin 8 and macrophage-derived neutrophil chemotactic factor inhibits neutrophil migration by stimulating nitric oxide production. Br J Pharmacol. 1998;124:1369-74.
22. Tavares-Murta BM, Machado JS, Ferreira SH, Cunha FQ. Nitric oxide mediates the inhibition of neutrophil migration induced by systemic administration of LPS. Inflamm. 2001;25:247-53.
23. Mestriner FLAC, Spiller F, Laure HJ, Souto FO, Tavares-Murta BM, Rosa JC, et al. Acute-phase protein alpha-1-acid glycoprotein mediates neutrophil migration failure in sepsis by a nitric oxide-dependent mechanism. Proc Natl Acad Sci U S A. 2007;104:19595-600.
24. Lutgendorf SK, Weinrib AZ, Penedo F, Russell D, DeGeest K, Constanzo ES, et al. Interleukin-6, cortisol, and depressive symtoms in ovarian cancer patients. J Clin Oncol. 2008;26:4820-7.
25. Mojtahedi Z, Khademi B, Hashemi SB, Abtahi SM, Ghasemi MA, Fattahi MJ, et al. Serum interleukine-6 concentration, but not interleukine-18, is associated with head and neck squamous cell carcinoma progression. Pathol Oncol Res. 2011;17:7-10.
26. Lyon DE, McCain NL, Walter J, Schubert C. Cytokine comparisons between women with breast cancer and women with a negative breast biopsy. Nurs Res. 2008;57:51-8.
27. Kassim SK, El-Salahy EM, Fayed ST, Helal SA, Helal T, Azzam Eel-D, et al. Vascular endothelial growth factor and interleukin-8 are associated with poor prognosis in epithelial ovarian cancer patients. Clin Biochem. 2004;37:363-9.
28. Mustea A, Braicu EL, Koensgen D, Yuan S, Sun PM, Stamatian F, et al. Monitoring of IL-10 in the serum of patients whit advanced ovarian cancer: results from a prospective pilot-study. Cytokine. 2009;45:8-11.
29. Beevi SS, Rasheed MH, Geetha A. Evidence of oxidative and nitrosative stress in patients with cervical squamous carcinoma. Clin Chim Acta. 2007;375:119-23.
30. Sharma A, Rajappa M, Sharma M. Cytokines (TH1 and TH2) in patients with advanced cervical cancer undergoing neoadjuvant chemoradiation: correlation with treatment response. Int J Gynecol Cancer. 2009;19: 1269-75.
31. Dincer Y, Akcay T, Tortum OB, Dogusoy G. Nitric oxide and antioxidant defense in patients with gastric cancer. Dig Dis Sci. 2006;51:1367-70.
32. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet. 2001;357:539-45.
33. Kasprzyk M, Dyszkiewicz W, Zwarun D, Lesniewska K, Wiktorowicz K. The assessment of acute phase proteins as prognostic factors in patients surgically treated for non-small cell lung cancer. Pneumonol Alergol Pol. 2008;76:321-6.